ArcticZymes signs supply agreement with GE Healthcare Life Sciences

ArcticZymes AS has signed a supply agreement with GE Healthcare Life Sciences for the supply of products based on ArcticZymes’ unique heat-labile enzyme portfolio.  “This agreement is another important result of our strategy to focus on the global leaders in molecular biology. We are proud to see GE Healthcare Life Sciences becoming one of our business partners in this market” says …

ArcticZymes awarded NOK 5 million research grant

ArcticZymes AS, a subsidiary company of Biotec Pharmacon ASA, has received a grant of NOK 5 million from the The Research Council of Norway, for a project titled “Functionalization of enzymes from marine bioprospecting”. The total project budget is NOK approx. 10 million over 3 years. The project is a user driven innovation project which aims to accelerate the commercialization …